Pancreatic Beta-Cell Proliferation Induced by Estradiol-17β is Foxo1 Dependent.

Estradiol-17 (E2) and the Foxo1 transcription factor have each been implicated in the regulation of -cell proliferation. Interaction between Foxo1and estrogen receptor alpha (ER), effecting cell cycle, has been demonstrated in breast cancer cells, but has not been studied thus far in -cells. Using human islets and the INS1-E -cell line, this study investigated the contribution of Foxo1 to E2-mediated -cell replication. Foxo1 expression was knocked down in INS1-E cells using siRNA and Foxo1 activity was inhibited in human islets with a specific Foxo1 inhibitor (AS1842856). Cells were treated with E2 and the ER agonist PPT and evaluated for proliferation by (3) [H]-thymidine incorporation and for transcriptional activity through the estrogen response element by the luciferase assay. As Foxo1 activity is regulated by post-translational modifications, the effect of E2 on phosphorylation was also assessed. In INS1-E cells, knock down of Foxo1 abrogated the proliferative response to E2 and PPT. In human islets, inhibition of Foxo1 abrogated E2-mediated proliferation and attenuated the response to PPT. Foxo1 knock down and inhibition reduced activity through the estrogen response element by 25% (p<0.05) and 50% (p<0.01) respectively, in INS1-E cells. E2 increased Foxo1 phosphorylation in a time dependent manner in INS1-E and human islets (p<0.01, p<0.05, respectively). These findings suggest that Foxo1 is involved in E2-mediated proliferation in INS1-E cells and human islets. This may have implications vis-a-vis variations in circulating endogenous E2 concentrations in diabetes.